Geojit Financial Services research report on Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences Ltd (KIMS) is an India-based company providing medical and healthcare services. In Q4FY24, consolidated revenue grew 10% YoY to Rs. 634cr, driven by strong growth in key operational metrics across geographies. EBITDA margin narrowed 320 bps to 25.1% YoY owing to higher employee costs and other operating expenses. KIMS is strategically positioned to bolster its market share by expanding its hospital reach to new geographies. The continuous addition of skilled doctors and advancement of technologies should further boost its vision and performance.
Outlook
Hence, we reiterate our ACCUMULATE rating on the stock with a revised target price of Rs. 2,164 based on 35x FY26E adjusted EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.